Safety, hemodynamic effects, and detection of acute xenon inhalation: rationale for banning xenon from sport
(Sicherheit, hämodynamische Wirkungen und Erkennung der akuten Xenon-Inhalation: Gründe für ein Verbot von Xenon im Sport)
This study aimed to quantify the sedative effects, detection rates, and cardiovascular responses to xenon. On 3 occasions, participants breathed xenon (FiXe 30% for 20 min; FiXe 50% for 5 min; FiXe 70% for 2 min) in a nonblinded design. Sedation was monitored by a board-certified anesthesiologist. During 70% xenon, participants were also verbally instructed to operate a manual value with time-to-task failure being recorded. Beat-by-beat hemodynamics were measured continuously by ECG, photoplethysmography, and transcranial Doppler. Over 48 h postadministration, xenon was measured in blood and urine by gas chromatography-mass spectrometry. Xenon caused variable levels of sedation and restlessness. Task failure of the self-operating value occurred at 60-90 s in most individuals. Over the first minute, 50% and 70% xenon caused a substantial reduction in total peripheral resistance (P < 0.05). All dosages caused an increase in cardiac output (P < 0.05). By the end of xenon inhalation, slight hypertension was observed after all three doses (P < 0.05), with an increase in middle cerebral artery velocity (P < 0.05). Xenon was consistently detected, albeit in trace amounts, up to 3 h after all three doses of xenon inhalation in blood and urine with variable results thereafter. Xenon inhalation caused sedation incompatible with self-operation of a breathing apparatus, thus causing a potential life-threatening condition in the absence of an anesthesiologist. Yet, xenon can only be reliably detected in blood and urine up to 3 h postacute dosing.
NEW & NOTEWORTHY Breathing xenon in dosages conceivable for doping purposes (FiXe 30% for 20 min; FiXe 50% for 5 min; FiXe 70% for 2 min) causes an initial rapid fall in total peripheral resistance with tachycardia and thereafter a mild hypertension with elevated middle cerebral artery velocity. These dose duration intervals cause sedation that is incompatible with operating a breathing apparatus and can only be detected in blood and urine samples with a high probability for up to ~3 h.
© Copyright 2019 Journal of Applied Physiology. American Physiological Society. Alle Rechte vorbehalten.
| Schlagworte: | |
|---|---|
| Notationen: | Biowissenschaften und Sportmedizin |
| Veröffentlicht in: | Journal of Applied Physiology |
| Sprache: | Englisch |
| Veröffentlicht: |
2019
|
| Online-Zugang: | https://doi.org/10.1152/japplphysiol.00290.2019 |
| Jahrgang: | 127 |
| Heft: | 6 |
| Seiten: | 1511-1518 |
| Dokumentenarten: | Artikel |
| Level: | hoch |